surveys program shipping - college of american pathologists€¦ · surveys program shipping. look...

Surveys Program Shipping

Surveys P

rogram S

hipping

Gain more value from your accreditation program.CAP accreditation is more than “something to check off your list.” It is an opportunity to help keep your laboratory operating at peak performance.

• The CAP offers educational material and support, including highly-trained medical technologists who are available to answer questions.

• The peer inspection model helps participants develop meaningful connections, learn from each other, and share best practices.

Sur

veys

Pro

gram

Shi

ppin

g

Look for notification of kit shipment via CAPTRAKerSM. If you do not receive your kit within 7 –10 calendar days following the ship date, or if you receive an incomplete or damaged shipment, please call the Customer Contact Center at 800-323-4040 or 847-832-7000 option 1. R equests for replacements after the 10th calendar day cannot be accepted.

SM

2020 Surveys Program Shipping

2 College of American Pathologists 2020 Surveys & Anatomic Pathology Education Programs


Prog Code

PFGCode

Description Page Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

A2MG A2MG Alpha-2-Macroglobulin 210 A 10 B 27

AABT AABT Antibody Titer—Automated 224 A 1 B 26

AABT1 AABT Antibody Titer—Automated 224 A 1 B 26



AAT AAT CAP/ACMG Alpha-1 Antitrypsin Genotyping 245 A 27 B 9

ABF1 ABF1 Automated Body Fluid 148 A 18 B 17



ABGIC ABGIC Accuracy-Based Glucose, Insulin, and C-Peptide

115 A 24 B 15

ABL ABL Accuracy-Based Lipids 112 A 16 B 10

ABOSG ABOSG ABO Subgroup Typing 222 A 23 B 27

ABS ABS Accuracy-Based Testosterone, Estradiol 113 A 11 B 14

ABT ABT Antibody Titer, Anti-A and Anti-D 223 A 1 B 26

ABT1 ABT Antibody Titer, Anti-A 223 A 1 B 26

ABT2 ABT Antibody Titer, Anti-D 223 A 1 B 26

ABT3 ABT Antibody Titer, Anti-B 223 A 1 B 26

ABTH ABTH Harmonized Thyroid 114 A 5 B 10

ABU ABU Accuracy-Based Urine 113 A 7 B 15

ABVD ABVD Accuracy-Based Vitamin D 112 A 24 B 6

ACA ACA Antichromatin Antibody 210 A 19 B 3

ACE ACE Angiotensin Converting Enzyme 71 A 30 B 21

ACL ACL Antiphospholipid Antibody 211 A 18 B 2

ADL ADL Aldolase 71 A 18 B 19

AFD AFD Antifungal Drugs Monitoring 106 A 12 B 17

AFL AFL Amniotic Fluid Leakage 148 A 11 B 14

AG AG 1,5-Anhydroglucitol 71 A 30 B 19

AHIV AHIV Anti-HIV 1/2 231 A 30 B 10 C 30

AHIVW AHIVW Anti-HIV 1/2, Waived 231 A 10 B 30

AHT S2 Antihistone Antibody 210 A 6 C 14

AL1 AL1 CAP/AACC Whole Blood Alcohol/Volatiles 101 A 24 B 8 C 28

AL2 AL2 CAP/AACC Serum Alcohol/Volatiles 101 A 10 B 1 C 5

AMH AMH Antimüllerian Hormone 84 A 27 B 9

ANA S Antinuclear Antibody 208 A 23 B 17 C 16

APC GIH Autoimmune Gastritis Markers 210 A 27 B 28

APOE APOE CAP/ACMG Apolipoprotein E Genotyping 245 A 2 B 14

APS ACL Antiphosphatidylserine Antibody 211 A 18 B 2

APT APT Fetal Hemoglobin 150 A 3 B 28

Surveys P

rogram S

hipping


SM

2020 Surveys Program Shipping (Continued)


800-323-4040 | 847-832-7000 Option 1 | cap.org 3

Prog Code

PFGCode


APXBN ACM Apixaban Anticoagulant Monitoring 163 A 14 B 26

AQ AQ Critical Care Blood Gas 92 A 24 B 22 C 19

AQ2 AQ Critical Care Blood Gas with Chemistry 92 A 24 B 22 C 19

AQ2Q AQQ Quality Cross Check—Blood Gas with Chemistry

44 A 23 B 10

AQ3 AQI Critical Care Blood Gas, i-STAT® 92 A 24 B 22 C 19

AQ3Q AQIQ Quality Cross Check—Blood Gas, i-STAT 44 A 23 B 10

AQ4 AQI Critical Care Blood Gas with Chemistry, i-STAT

92 A 24 B 22 C 19

AQ4Q AQIQ Quality Cross Check—Blood Gas with Chemistry, i-STAT

44 A 23 B 10

AQQ AQQ Quality Cross Check—Blood Gas 44 A 23 B 10

ARP ARP Antiribosomal P Antibody 211 A 19 B 24

ASA SEM Antisperm Antibody 156 A 20 B 26

ASC ASC Anti-Saccharomyces cerevisiae Antibody 211 A 11 B 7

ASO S Antistreptolysin O 208 A 23 B 17 C 16

AUP AUP Autopsy Pathology 283 A 23 B 12

AUP1 AUP Autopsy Pathology, Additional Pathologist 283 A 23 B 12

B27 B27 HLA-B27 Typing 237 A 14 B 25

BALL BALL Flow Cytometry—B-ALL Minimal Residual Disease

216 A 13 B 6

BCP KP Blood Cell ID, Photographs 139 A 27 B 4 C 21

BCP2 KP Blood Cell ID, Limited 139 A 27 B 4 C 21

BCR CRS Bile Crystals 149 A 29 B 30

BCS BCS Blood Culture 178 A 29 B 26

BCS1 BCS1 Blood Culture, S. aureus 179 A 30 B 14

BDP BDP Bacterial Detection in Platelets, 2 Challenge

228 A 20 B 19

BDP5 BDP5 Bacterial Detection in Platelets, 5 Challenge

228 A 20 B 13 C 19

BDPV BDPV Bacterial Detection in Platelets, Rapid, 2 Challenge

228 A 21 B 20

BDPV5 BDPV5 Bacterial Detection in Platelets, Rapid, 5 Challenge

228 A 21 B 14 C 20

BFC CRS Body Fluid Crystals 149 A 29 B 30

BGL BGL CAP/ACMG Biochemical Genetics 245 A 11 B 18

BGL1 BGL CAP/ACMG Carnitine, Qual/Quant 245 A 11 B 18

BGS Y Bone and Growth 85 A 27 B 21

BL BL CAP/AACC Blood Lead 102 A 16 B 13 C 26

BMD BMD Bone Marrow Cell Differential 139 A 23 B 24

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


BMV1 BMV 1,25 Dihydroxy Vitamin D 86 A 6 B 17

BMV2 BMV Bone-Specific Alkaline Phosphatase 86 A 6 B 17

BMV3 BMV Vitamin A 86 A 6 B 17

BMV4 BMV Vitamin E 86 A 6 B 17

BMV5 BMV C-Telopeptide 86 A 6 B 17

BMV6 BMV N-Telopeptide 86 A 6 B 17

BNP BNP B-Type Natriuretic Peptides, 2 Challenge 61 A 4 B 27

BNP5 BNP5 B-Type Natriuretic Peptides, 5 Challenge 61 A 4 B 9 C 27

BNPQ BNPQ Quality Cross Check—BNP 41 A 27 B 2

BOR BOR B. pertussis/parapertussis, Molecular 180 A 20 B 9

BP BP Blood Parasite 193 A 27 B 18 C 21

BRAF BRAF BRAF 260 A 4 B 9

BRAFV BRAFV BRAF V600EIHC 278 A 18 B 30

BRCA BRCA CAP/ACMG BRCA 1/2 Sequencing 246 A 20 B 9

BSTS BST Bacterial Strain Typing, Staphylococcus 178 A 13 B 17

BU Y Bone and Mineral Metabolism, Urine 85 A 27 B 21

BV BV Bacterial Vaginosis 184 A 30 B 26

C1 C Chemistry—General, Limited 56–58 A 9 B 1 C 28

C3 C Chemistry—General, Comprehensive 56–58 A 9 B 1 C 28

C3X C Chemistry—General, Double Volume 56–58 A 9 B 1 C 28

C4 C Chemistry—Limited 56–58 A 9 B 1 C 28

C7 C Pseudocholinesterase 77 A 9 B 1 C 28

CAMP CAMP Campylobacter 180 A 13 B 17

CBT* CBT Cord Blood Testing 227 A 21 B 4

CCP RDS Cyclic Citrullinated Peptide Antibody (Anti-CCP)

212 A 6 B 17

CD CD Cadmium 102 A 21 B 2 C 1 D 3 E 21 F 23

CD30 CD30 CD30 Immunohistochemistry Tissue Microarray

279 A 23 B 14

CDF2 CDF C. diff, 2 Challenge 180 A 20 C 7

CDF5 CDF C. diff, 5 Challenge 181 A 20 B 10 C 7

CES CES Celiac Serology 212 A 9 B 14

CESX CES Celiac Serology, Additional Volume 212 A 9 B 14

CFDNA CFDNA Cell-free Tumor DNA 260 A 28 B 29

CGB CGL Coagulation—Basic 160 A 27 B 11 C 24

CGDF CGL D-dimer/FDP 160 A 27 B 11 C 24

CGE CGE Coagulation—Extended 161 A 23 B 28

CGEX CGE Coagulation—Extended, Additional Material

161 A 23 B 28

CGL CGL Coagulation—Limited 160 A 27 B 11 C 24

*Ship date subject to change.

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 5

Prog Code

PFGCode


CGLQ CGLQ Quality Cross Check—Coagulation 47 A 6 B 5

CGM CGM Coagulation—Limited, Validated Material 169 A 27 B 11 C 24

CGS1 CGS1 Lupus Anticoagulant and Mixing Studies 162 A 16 B 31

CGS2 CGS2 Thrombophilia 162 A 16 B 31

CGS3 CGS3 von Willebrand Factor Antigen 162 A 16 B 31

CGS4 CGS4 Heparin 162 A 16 B 31

CGS5 CGS5 Heparin-Induced Thrombocytopenia 162 A 14 B 19

CGS7 CGS7 ADAMTS13 162 A 6 B 14

CH50 CH50 Total Hemolytic Complement 214 A 20 B 2

CHPVD CHPV Human Papillomavirus, Digene 287 A 2 B 3 C 14

CHPVJ CHPV Human Papillomavirus, Mixed Media 287 A 2 B 3 C 14

CHPVK CHPV Human Papillomavirus, SurePath 287 A 2 B 3 C 14

CHPVM CHPV Human Papillomavirus, ThinPrep 287 A 2 B 3 C 14

CMMP CM Clinical Microscopy Miscellaneous Photopage

147 A 18 B 8

CMP CM Urinalysis w/Body Fluid & Urine Sediment Photos

146 A 18 B 8

CMP1 CM iChem Urinalysis w/Body Fluid & Urine Sediment Photos

146 A 18 B 8

CMQ CMQ Quality Cross Check—Urinalysis 46 A 11 B 16

CMSP CMSP CAP/ACMG Cardiomyopathy Sequencing Panel

246 A 14 B 13

CPIP CPIP Clinical Pathology Improvement Program 14 A 20 B 17 C 16 D 20 E 18 F 15 G 20 H 17 I 21 J 19 K 16 L 21

CPIP1 CPIP Clinical Pathology Improvement Program, Additional Participant

14 A 20 B 17 C 16 D 20 E 18 F 15 G 20 H 17 I 21 J 19 K 16 L 21

CRO CRO Carbapenem-resistant Organisms 180 A 23 B 14

CRP S C-Reactive Protein 208 A 23 B 17 C 16

CRT CAR Cardiac Markers 62 A 17 B 19 C 6

CRTI CAR Cardiac Markers, Isoenzymes & Troponin I 62 A 17 B 19 C 6

CRTQ CRTQ Quality Cross Check—Cardiac Markers 42 A 14 B 15

CRYP CRYP Cryptococcal Antigen Detection 190 A 16 B 8 C 28

CS CSM CAP/AACC Immunosuppressive Drugs 59 A 9 B 23

CT CT Activated Clotting Time 164 A 21 B 20

CT1 CT1 Activated Clotting Time 164 A 6 B 20

CT1Q CT1Q Quality Cross Check—ACT 48 A 1 B 7





Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode




CTKN CTKN Cytokines 212 A 2 B 17

CTQ CTQ Quality Cross Check—ACT 48 A 1 B 7

CY CY CAP/ACMG Cytogenetics, Online Images 242 A 30 B 2

CYBK CY CAP/ACMG Cytogenetics, Booklet 242 A 30 B 2

CYCGH CYCGH CAP/ACMG Constitutional Microarray 244 A 18 B 19

CYCMA CYCMA CAP/ACMG Oncology Microarray 244 A 9 B 3

CYF CYF CAP/ACMG FISH Constitutional/Hematologic Disorders

242 A 14 B 31

CYH CYH CAP/ACMG FISH, Paraffin-Embedded Tissue

243 A 21 B 6

CYHI CYHI CAP/ACMG HER2 Gene Amplification by FISH, Interpretation Only

282 A 21 B 6

CYI CYI CAP/ACMG FISH, Urothelial Carcinoma 242 A 24 B 3

CYJ CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

243 A 23 B 3

CYK CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

243 A 23 B 3

CYL CYP CAP/ACMG FISH, Paraffin-Embedded Tissue

243 A 23 B 3

CYS CYS Cystatin C 74 A 13 B 31

CZ C Chemistry/Therapeutic Drug Monitoring 56–58 A 9 B 1 C 28

CZ2X C Chemistry/TDM, Triple Volume 56–58 A 9 B 1 C 28

CZQ CZQ Quality Cross Check—Chemistry/Therapeutic Drug Monitoring

41 A 14 B 8

CZVM CZVM Chemistry/TDM, Validated Material 67 A 9 B 1 C 28

CZX C Chemistry/TDM, Double Volume 56–58 A 9 B 1 C 28

D D Bacteriology 173 A 3 B 8 C 5

D1 D1 Throat Culture 175 A 30 B 10 C 7

D2 D2 Urine Culture 175 A 30 B 10 C 7

D3 D3 N. gonorrhoeae Culture 175 A 30 B 10 C 7

D5 D5 Gram Stain 176 A 6 B 17 C 7

D6 D6 Rapid Group A Strep Antigen Detection 177 A 30 B 10 C 7

D8 D8 Group B Strep Detection 178 A 27 B 13 C 30

D9 D9 Rapid Group A Strep Antigen Detection, Waived

177 A 30 B 10

DADR1 DADR HLA Disease Association-Drug Risk 240 A 14 B 25

DADR2 DADR HLA Disease Association-Drug Risk 240 A 14 B 25

DAI DAI Urine Drug Adulterant/Integrity 98 A 10 B 10

DAT DAT Direct Antiglobulin Testing 224 A 24 B 12

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 7

Prog Code

PFGCode


DBGN ACM Dabigatran Anticoagulant Monitoring 163 A 14 B 26

DEX DEX Expanded Bacteriology 174 A 13 B 18 C 7

DFC DFC Drug-Facilitated Crime 108 A 2 B 1

DML DML Class I & II HLA Molecular Typing 237 A 17 B 2 C 29

DMPM DMPM Drug Monitoring for Pain Management 107 A 10 B 10

DPATH DPATH Digital Slide Program—Dermatopathology 267 A 15 B 14

DPATH1 DPATH Digital Slide Program—Dermpath, Additional Pathologist

267 A 15 B 14

DPIHC DPIHC Dermatopathology IHC 278 A 11 B 8

DSC CM Dipstick Confirmatory Testing 149 A 18 B 8

DY Y Ligand Assay—Testosterone, SHBG 84 A 27 B 21

E E Mycobacteriology 188 A 2 B 31

E1 E1 Mycobacteriology—Limited 188 A 24 B 24

EGFR EGFR EGFR 260 A 2 B 31

EHE1 EHE Expanded Virtual Peripheral Blood Smear 144 A 20 B 19

ELU ELU Eluate 224 A 16 B 29

EMB EMB Embryology 157 A 8 B 26

EPO Y Erythropoietin 88 A 27 B 21

ESR ESR Erythrocyte Sedimentation Rate 140 A 18 B 16

ESR1 ESR1 Erythrocyte Sedimentation Rate 140 A 18 B 16



ETB ETB Ethanol Biomarkers 102 A 2 B 31

ETME1 ETME Expanded Transfusion Medicine Exercises 229 A 9 B 28

EV EV Everolimus 60 A 21 B 15

EXM J Electronic Crossmatch 221 A 10 C 8

EXM2 JAT Electronic Crossmatch, Automated 222 A 18 C 28

F F Mycology and Aerobic Actinomycetes 189 A 27 B 4 C 24

F1 F1 Yeast 189 A 18 B 26 C 14

F3 F3 Candida Culture 190 A 2 B 6 C 9

FCAL FCAL Fecal Calprotectin 75 A 27 B 16

FCFS FCFS Fecal Fat 75 A 2 B 14

FCN FCN Antifilamentous Actin IgG Antibody 210 A 27 B 9

FF FF Fetal Fibronectin 88 A 29 B 30

FGAL FGAL Galactomannan 190 A 13 B 17

FH1 FH1 Hematology Automated Differential Series 136 A 27 B 4 C 21

FH1P FH1 Hematology Automated Differential Blood Cell ID

136 A 27 B 4 C 21


Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode



136 A 27 B 4 C 21



136 A 27 B 4 C 21

FH3Q FH3Q Quality Cross Check—Hematology 45 A 24 B 20



136 A 27 B 4 C 21




136 A 27 B 4 C 21




136 A 27 B 4 C 21




136 A 27 B 4 C 21



136 A 27 B 4 C 21

FH15 FH15 Centrifugal Hematology 137 A 23 B 20 C 23

FL FL Flow Cytometry Combo (FL1/FL2) 215 A 9 B 15 C 12

FL1 FL Flow Cytometry, Lymphocyte Phenotype 215 A 9 B 15 C 12

FL2 FL Flow Cytometry, DNA Analysis 215 A 9 B 15 C 12

FL3 FL3 Flow Immunophenotypic Characterization of Leukemia/Lymphoma

215 A 3 B 15

FL4 FL4 Flow Cytometry, CD34+ 215 A 14 B 19

FL5 FL5 Flow Cytometry, Interpretation Only 216 A 10 B 17

FL6 FL6 Flow Cytometry—Post-Immunotherapy Analysis

216 A 26 B 30

FLAC FLAC Fecal Lactoferrin 181 A 20 B 24

FLD FLD Body Fluid Chemistry 72 A 10 B 3

FLD2 FLD2 Body Fluid Chemistry 2 73 A 10 B 3

FLDQ FLDQ Quality Cross Check—Body Fluid Chemistry

42 A 13 B 12

FNA FNA Digital Slide Program in Fine-Needle Aspiration

290 A 20 B 19

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 9

Prog Code

PFGCode


FNA1 FNA Digital Slide Program in Fine-Needle Aspiration, Individual

290 A 20 B 19

FNAG FNAG Fine-Needle Aspiration Glass Slides, Laboratory

291 A 11 B 14

FNAG1 FNAG Fine-Needle Aspiration Glass Slides, Individual

291 A 11 B 14

FNPX ACM Fondaparinux Anticoagulant Monitoring 163 A 14 B 26

FOL K RBC Folate 88 A 6 B 20 C 9

FP FP Second Trimester Maternal Screening 87 A 16 B 3 C 9

FP1B FP First Trimester Maternal Screening, Free Beta

87 A 16 B 3 C 9

FP1T FP First Trimester Maternal Screening, Total Beta

87 A 16 B 3 C 9

FPX FP Second Trimester Maternal Screening, Additional Material

87 A 16 B 3 C 9

FR FR Forensic Pathology 294 A 18 B 23

FR1 FR Forensic Pathology, Additional Pathologist 294 A 18 B 23

FSER FSER Fungal Serology 190 A 20 B 24

FSM FSM Fungal Smear 191 A 23 B 5

FT FT Fructosamine 75 A 4 B 9

FTC FTC Forensic Toxicology, Criminalistics 104 A 9 B 14

G G Syphilis Serology 214 A 14 B 27 C 14

G6PDS G6PDS Glucose-6-Phosphate Dehydrogenase 75 A 23 B 12

GH2 GH2 Hemoglobin A1c, 3 Challenge 63 A 21 B 8

GH5 GH5 Hemoglobin A1c, 5 Challenge 63 A 21 B 21 C 8

GH5I GH5I Hemoglobin A1c, International 63 A 9 B 15 C 12

GHER2 GHER2 Gastric HER2 281 A 23 B 17

GHQ GHQ Quality Cross Check—Hemoglobin A1c 42 A 8 B 9

GIP GIP Gastrointestinal Panel, 2 Challenge 204 A 30 B 3

GIP5 GIP Gastrointestinal Panel, 5 Challenge 204 A 30 B 3 C 14

GLI GLI Glioma 261 A 16 B 17

GNBC GPBC Gram-Negative Blood Culture Panel 179 A 30 B 28

GOCB CM Gastric Occult Blood 150 A 18 B 8

GPBC GPBC Gram-Positive Blood Culture Panel 179 A 30 B 28

GSA GSA Glycated Serum Albumin 64 A 4 B 9

H GIH Antimitochondrial M2 Antibody 210 A 27 B 28

HBF HBF Fetal Red Cell Detection 225 A 27 B 2

HBVL HVL Hepatitis B Viral Load, 3 Challenge 198 A 21 C 29

HBVL5 HVL Hepatitis B Viral Load, 5 Challenge 198 A 21 B 26 C 29

HC1 HC1 C. trachomatis Antigen Detection (DFA) 181 A 9 B 13 C 26

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


HC2 HC2 Herpes Simplex, Antigen Detection (DFA) 197 A 9 B 13 C 26

HC3 HC3 C. trachomatis Antigen Detection (EIA) 181 A 27 B 27 C 8

HC4 HC4 Herpes Simplex Virus, Culture 197 A 24 B 8 C 21

HC6 HC6 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA)

186 A 3 B 18 C 21

HC6X HC6 C. trachomatis/N. gonorrhoeae by Nucleic Acid Amplification (NAA), Additional Material

186 A 3 B 18 C 21

HC7 HC7 C. trachomatis/N. gonorrhoeae with DNA 186 A 2 B 20 C 12

HCC HCC Waived Combination 66 A 10 B 21

HCC2 HCC2 Waived Combination 66 A 3 B 15 C 14 D 12

HCG S HCG, Serum 208 A 23 B 17 C 16

HCV2 HVL Hepatitis C Viral Load 198 A 21 B 26 C 29

HE HE Hematology—Basic 136 A 27 B 4 C 21

HEP HE Hematology—Basic with Blood Cell ID 136 A 27 B 4 C 21

HER2* HER2 HER2 Immunohistochemistry 281 A 16 B 3

HFC HFC Hemocytometer Fluid Count 150 A 3 B 7

HFCI HFCI Hemocytometer Fluid Count, International 151 A 14 B 7

HG HG Hemoglobinopathy 140 A 10 B 10

HGM HGM CAP/ACMG Hemoglobinopathies Genotyping

247 A 2 B 9

HIVG HIV HIV Genotyping 199 A 21 B 26 C 29

HMS CR Homocysteine 64 A 30 B 2

HPATH HPATH Hematopathology Online Education 145 A 18 B 16

HPATH1 HPATH Hematopathology Online Education, Additional Participant

145 A 18 B 16

HPS HPS H. pylori Antigen, Stool 181 A 30 B 14

HPV HPV Human Papillomavirus 197 A 22 B 19

HQBX1 HQBX1 CAP/NSH HistoQIP Gastrointestinal Biopsy 277 A 27 B 22

HQBX2 HQBX2 CAP/NSH HistoQIP Dermatologic Biopsy 277 A 27 B 22

HQBX3 HQBX3 CAP/NSH HistoQIP Urogenital Tract Biopsy 277 A 27 B 22

HQBX4 HQBX4 CAP/NSH HistoQIP Gynecological Biopsy 277 A 27 B 22

HQIHC HQIHC CAP/NSH HistoQIP Immunohistochemistry 274 A 27 B 22

HQIP HQIP CAP/NSH HistoQIP 271 A 27 B 22

HQIPBX HQIPBX CAP/NSH HistoQIP Biopsy Series 276 A 27 B 22

HQISH HQISH CAP/NSH HistoQIP In Situ Hybridization (Kappa/Lambda)

272 A 27 B 22

HQMEL HQMEL CAP/NSH HistoQIP Melanoma IHC 273 A 27 B 22

HQMMR HQMMR CAP/NSH HistoQIP Mismatch Repair IHC 275 A 27 B 22


Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 11

Prog Code

PFGCode


HQNEU HQNEU CAP/NSH HistoQIP Central Nervous System IHC

272 A 27 B 22

HQNSC HQNSC CAP/NSH HistoQIP Non-small Cell Lung Carcinoma IHC

276 A 27 B 22

HQWSI HQWSI HQIP Whole Slide Image Quality Improvement Program

274 A 27 B 22

HSCRP CR High-Sensitivity C-Reactive Protein 64 A 30 B 2

HUEP HUEP Human Epididymis Protein 4 89 A 21 B 27

HV2 HIV HIV Viral Load 199 A 21 B 26 C 29

I I Instrumentation 132 A 30 B 27 C 30

ICSP ICSP CAP/ACMG Inherited Cancer Sequencing Panel

247 A 25 B 18

ID1 ID1 Nucleic Acid Amplification, Viruses 197 A 13 B 19

ID1T ID1 Nucleic Acid Amplification, JC & BK 197 A 13 B 19

ID2 ID2 Nucleic Acid Amplification, Respiratory 198 A 13 B 19

ID3 ID3 Influenza A, Influenza B, and RSV by NAA 198 A 9 B 13 C 30

ID5 ID5 HSV, VZV—Molecular 198 A 13 B 31 C 14

IDME IDME Meningitis/Encephalitis Panel 202 A 6 B 31

IDN IDO NAA, Organisms Without MTB 201 A 13 B 19

IDO IDO Nucleic Acid Amplification, Organisms 201 A 13 B 19

IDPN IDPN Infectious Disease, Pneumonia Panel 203 A 13 B 31 C 14

IDR IDR Infectious Disease, Respiratory Panel 202 A 9 B 13 C 30

IFS IFS Interfering Substances 133 A 6

IG S Immunology—General 208 A 23 B 17 C 16

IGHV IGHV IGHV Mutation Analysis 258 A 31 B 3

IGX S Immunology—General, Double Volume 208 A 23 B 17 C 16

IL S Immunology—Comprehensive 208 A 23 B 17 C 16

IM S Infectious Mononucleosis 208 A 23 B 17 C 16

IMD1 IMD CAP/ACMG Mitochondrial DNA Deletion Syndrome

249 A 30 B 28

IMD2 IMD CAP/ACMG MCAD 249 A 30 B 28

IMD3 IMD CAP/ACMG Mitochondrial Cytopathies 249 A 30 B 28

IMW IMW Infectious Mononucleosis, Waived 209 A 30 B 10

IND IND India Ink 191 A 11 B 7

ING Y Insulin, Gastrin, C-Peptide, and PTH 86 A 27 B 21

ISH ISH In Situ Hybridization 258 A 21 B 6

ISH2 ISH In Situ Hybridization, HER2 (ERBB2) 258 A 21 B 6

J J Transfusion Medicine—Comprehensive 220 A 10 B 8 C 8

J1 J1 Transfusion Medicine—Limited 220 A 10 B 8 C 8

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


JAT JAT Transfusion Medicine—Automated 221 A 18 B 22 C 28

JATE1 JAT Transfusion Medicine—Automated Education Challenge

221 A 18 B 22 C 28

JATQ JATQ Quality Cross Check—Transfusion Medicine

49 A 14 B 3

JE1 J Transfusion Medicine—Education Challenge

220 A 10 B 8 C 8

K K Ligand—General 82 A 6 B 20 C 9

K2 K2 Ligand—Limited 82 A 6 B 9

KET KET Ketones 64 A 4 B 9

KIT KIT KIT/PDGFRA 260 A 14 B 26

KK K Ligand—General, Double Volume 82 A 6 B 20 C 9

KRAS KRAS KRAS 260 A 18 B 16

KSA KSA Kidney Stone Assessment 69 A 26 B 23

KVM KVM Ligand Assay—General, Validated Material 90 A 6 B 20 C 9

LBAS BAS Legionella Antigen Detection 178 A 2 B 9

LBC LBC Lamellar Body Count 151 A 20 B 26

LCW LCW Chemistry—Limited, Waived 64 A 2 B 12

LKM GIH Liver-Kidney Microsomal Antibody (Anti-LKM)

213 A 27 B 28

LN2 LN2 Chemistry, Lipid, Enzyme Calibration Verification/Linearity

120 A 15 B 7

LN2BV LN2BV Chem CVL Beck (Except AU), Vitros Calibration Verification/Linearity

120 A 15 B 7

LN3 LN3 Therapeutic Drug Monitoring Calibration Verification/Linearity

121 A 11 B 16

LN5 LN5 Ligand Assay Calibration Verification/Linearity

121-122 A 1 B 23

LN5S LN5S Ligand Assay, Siemens Calibration Verification/Linearity

121-122 A 1 B 23

LN6 LN6 Urine Chemistry Calibration Verification/Linearity

122 A 11 B 16

LN7 LN7 Immunology Calibration Verification/Linearity

123 A 20 B 12

LN8 LN8 Reproductive Endocrinology Calibration Verification/Linearity

123 A 6 B 28

LN9 LN9 Hematology Calibration Verification/Linearity

123 A 6 B 28

LN11 LN11 Serum Ethanol Calibration Verification/Linearity

124 A 13 B 6

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 13

Prog Code

PFGCode


LN12 LN12 C-Reactive Protein Calibration Verification/Linearity

124 A 21 B 27

LN12E LN12E C-Reactive Protein, Extended Calibration Verification/Linearity

124 A 21 B 27

LN13 LN13 Blood Gas Calibration Verification/Linearity 124-125 A 13 B 6

LN13C LN13 Blood Gas/Critical Care Calibration Verification/Linearity

124-125 A 13 B 6

LN15 LN15 Hemoglobin A1c Accuracy Calibration Verification/Linearity

125 A 10 B 15

LN16 LN16 Homocysteine Calibration Verification/Linearity

125 A 9 B 14

LN17 LN17 Whole Blood Glucose Calibration Verification/Linearity

125 A 24 B 24

LN18 LN18 Reticulocyte Calibration Verification/Linearity

126 A 23 B 28

LN19 LN19 Reticulocyte Calibration Verification/Linearity

126 A 16 B 14

LN20 LN20 Urine Albumin Calibration Verification/Linearity

126 A 14 B 12

LN21 LN21 High-Sensitivity CRP Calibration Verification/Linearity

126 A 14 B 12

LN22 LN22 Flow Cytometry Calibration Verification/Linearity

126 A 30 B 5

LN23 LN23 Prostate-Specific Antigen Calibration Verification/Linearity

127 A 26 B 23

LN24 LN24 Creatinine Accuracy Calibration Verification/Linearity

127 A 19 B 17

LN25 LN25 Troponin I Calibration Verification/Linearity 127 A 24 B 22

LN27 LN27 Troponin T Calibration Verification/Linearity

127 A 24 B 22

LN30 LN30 B-Type Natriuretic Peptides Calibration Verification/Linearity

128 A 16 B 15

LN31 LN31 Immunosuppressive Drugs Calibration Verification/Linearity

128 A 21 B 27

LN32 LN32 Ammonia Calibration Verification/Linearity 128 A 26 B 30

LN33 LN33 Serum Myoglobin Calibration Verification/Linearity

128 A 26 B 30

LN34 LN34 Tumor Markers Calibration Verification/Linearity

129 A 20 B 19

LN35 LN35 Thrombophilia Calibration Verification/Linearity

129 A 3 B 25

LN36 LN36 Heparin Calibration Verification/Linearity 129 A 31 B 29

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


LN37 LN37 von Willebrand Factor Antigen Calibration Verification/Linearity

129 A 28 B 27

LN38 LN38 CMV Viral Load Calibration Verification/Linearity

130 A 3 B 1

LN39 LN39 HIV Viral Load Calibration Verification/Linearity

130 A 4 B 2

LN40 LN40 Vitamin D Calibration Verification/Linearity 130 A 4 B 2

LN41 LN41 Procalcitonin Calibration Verification/Linearity

130 A 5 B 10

LN42 LN42 D-Dimer Calibration Verification/Linearity 131 A 14 B 12

LN43 LN43 Lamellar Body Count Calibration Verification/Linearity

131 A 27 B 2

LN44 LN44 Fibrinogen Calibration Verification/Linearity

131 A 12 B 10

LN45 LN45 HCV Viral Load Calibration Verification/Linearity

130 A 28 B 3

LN46 LN46 C-Peptide/Insulin Calibration Verification/Linearity

131 A 12 B 3

LPE ELP Lipoprotein Electrophoresis 76 A 27 B 10

LPX LPX Laboratory Preparedness Exercise 183 A 6 B 8

M M Cerebrospinal Fluid Chemistry 74 A 6 B 31

MBT MBT Micro Bench Tools Competency 174 A 30 B 28

MC3 MC3 Urine Colony Count 176 A 30 B 10 C 7

MC4 MC4 Urine Colony Count—Combination 176 A 30 B 10 C 7

ME ME Monitoring Engraftment 239 A 25 B 28 C 11

MGEN MGEN Mycoplasma genitalium, Molecular 185 A 26 B 30

MGL1 MGL1 Molecular Genetics Series 248–249 A 16 B 10





MHO MHO MHO, Lymphoma 262 A 21 B 20

MHO1 MHO MHO1, Lymphoma, Double Volume 262 A 21 B 20

MHO2 MHO MHO2, Leukemia Only 262 A 21 B 20

MHO3 MHO MHO3, Leukemia Only, Double Volume 262 A 21 B 20

MHO5 MHO DNA Extraction & Amplification FFPE 259, 262 A 21 B 20

MK MK Immunohistochemistry 278 A 18 B 17

MMA MMA MMA and Active B13 82 A 21 B 6

MMR MMR DNA Mismatch Repair 278 A 15 B 19

MPA CSM Mycophenolic Acid 60 A 9 B 23

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 15

Prog Code

PFGCode


MRD MRD Minimal Residual Disease, BCR/ABL1 p210 262 A 21 B 6

MRD1 MRD Minimal Residual Disease, BCR/ABL1 p190 262 A 21 B 6

MRD2 MRD Minimal Residual Disease, PML/RARA 262 A 21 B 6

MRS MRS Methicillin-resistant Staphylococcus aureus, 2 Challenge

182 A 3 B 5

MRS2M MRS2M MRSA Screen, Molecular, 2 Challenge 182 A 30 B 2

MRS5 MRS5 Methicillin-resistant Staphylococcus aureus, 5 Challenge

182 A 3 B 1 C 5

MRS5M MRS5M MRSA Screen, Molecular, 5 Challenge 182 A 30 B 13 C 2

MSI MSI Microsatellite Instability 258 A 15 B 19

MTBR MTBR Molecular MTB ID & Resistance Detection 188 A 8 B 16

MTP MTP Multigene Tumor Panel 261 A 18 B 24

MVM MVM Cerebrospinal Fluid, Validated Material A 6 B 31

MVP MVP Molecular Vaginal Panel 185 A 23 B 6 C 16

MX1B MX1 HLA XMatch, Antibody Screen & ID (Class I) 236 A 28 B 19 C 20

MX1C MX1 HLA XMatch, Antibody Screen & ID (Class I) 236 A 28 B 19 C 20

MX1E MX1 HLA Antibody Screen & ID (Class I) 236 A 28 B 19 C 20

MX2B MX2 HLA XMatch, Antibody Screen & ID (Class II)

236 A 31 B 28 C 17

MX2C MX2 HLA XMatch, Antibody Screen & ID (Class II)

236 A 31 B 28 C 17

MX2E MX2 HLA Antibody Screen & ID (Class II) 236 A 31 B 28 C 17

MXBMX1 MX1B/MX2B Combination, Class I & II

237A 28 B 19 C 20

MX2 A 31 B 28 C 17

MXCMX1 MX1C/MX2C Combination, Class I & II

237A 28 B 19 C 20

MX2 A 31 B 28 C 17

MYBC MYBC c-Myc/Bcl-2 Immunohistochemistry TMA 279 A 14 B 12

MYG MYG Myoglobin, Urine 69 A 24 B 20

N N Urine Chemistry—Special 69 A 24 B 13

NAT NAT Nucleic Acid Testing 232 A 16 B 13 C 12

NB NB Neonatal Bilirubin, 5 Challenge 65 A 2 B 15 C 19

NB2 NB2 Neonatal Bilirubin, 2 Challenge 65 A 2 B 19

NEO NEO Neoplastic Cellularity 259 A 9 B 21

NGC NGC Non-GYN Interlaboratory Comparison, Lab 289 1/21/20 -

2/10/20

4/13/20 -

5/4/20

7/20/20 -

8/10/20

10/12/20 -

11/2/20

NGC1 NGC Non-GYN Interlaboratory Comparison, Indv 289 1/21/20 -

2/10/20

4/13/20 -

5/4/20

7/20/20 -

8/10/20

10/12/20 -

11/2/20

NGS NGS Next-Generation Sequencing—Germline 254 A 2 B 14

NGSB1 NGSB NGS Bioinformatics for Illumina 255 A 1 B 23

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


NGSB2 NGSB2 NGS Bioinformatics for Ion Torrent 255 A 1 B 23

NGSBV NGSBV NGS Bioinformatics Somatic, Validated Material

257 A 8 B 23

NGSE NGSE NGS Undiagnosed Disorders-Exome 256 A 2 B 14

NGSHM NGSHM NGS Hematologic Malignancies 255 A 28 B 27

NGSST NGSST NGS Solid Tumor 254 A 24 B 29

NIPT NIPT Noninvasive Prenatal Testing 88 A 27 B 14

NOB NOB Novel Opioids and Benzodiazepines 105 A 14 B 1

NP NP Neuropathology Program 284 A 16 B 14

NP1 NP Neuropathology Program, Additional Pathologist

284 A 16 B 14

NTA NTA Nicotine and Tobacco Alkaloids 102 A 28 B 3

NX N Urine Chemistry—Special, Double Volume 69 A 24 B 13

OCB CM Occult Blood 151 A 18 B 8

OCBQ OCBQ Quality Cross Check—Occult Blood 46 A 14 B 19

OFD OFD Oral Fluid for Drugs of Abuse 100 A 2 B 26 C 31 D 30

OLI M CSF Chemistry and Oligoclonal Bands 74 A 6 B 31

P P Parasitology 192 A 2 B 22 C 2

P16 P16 p16 Immunohistochemistry Tissue Microarray

279 A 14 B 16

P3 P Parasitology—Fecal Suspension, Immunoassay

192 A 2 B 22 C 2

P4 P Parasitology—Fecal Suspension, PVA, Immunoassay

192 A 2 B 22 C 2

P5 P Parasitology, Giardia/Crypto Immunoassay 192 A 2 B 22 C 2

PAP Prog PAP PAP PT and Education Programs 285-286 For PAP shipping information, refer to page 23

PARF PARF Parentage/Relationship Test—Filter Paper 233 A 18 B 22 C 21

PCARI PCARM Plasma Cardiac Markers International 65 A 2 B 8 C 12

PCARM PCARM Plasma Cardiac Markers 65 A 2 B 8 C 12

PCARMX PCARM Plasma Cardiac Markers, Double Volume 65 A 2 B 8 C 12

PCNEO PCNEO Flow Cytometry—Plasma Cell Neoplasms 217 A 28 B 13

PCP1 PCP1 Pneumocystis, Calcofluor White Stain 191 A 1 B 7

PCP2 PCP2 Pneumocystis, DFA Stain 191 A 1 B 7

PCP4 PCP4 Pneumocystis, GMS Stain 191 A 1 B 7

PCT PCT Procalcitonin 77 A 2 B 24

PDL1 PDL1 PD-L1 279 A 26 B 9

PEX PEX Expanded Parasitology 193 A 13 B 12

PF PF Platelet Aggregation 166 A 9 B 12

PF1 PF1 Platelet Function 166 A 9 B 12

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 17

Prog Code

PFGCode


PGX PGX Pharmacogenetics 251 A 20 B 14

PGX1 PGX IL28B Genotyping 251 A 20 B 14

PGX2 PGX HLA Drug Hypersensitivity 251 A 20 B 14

PGX3 PGX DPYD, TPMT, UGT1A1 Genotyping 251 A 20 B 14

PHG PHG Plasma Hemoglobin 76 A 30 B 14

PIA PIA Drug-Specific Platelet Aggregation 167 A 14 B 19

PIAX PIA Drug-Specific Platelet Aggregation, Double Volume

167 A 14 B 19

PIP PIP Performance Improvement Program in Surgical Pathology

265 A 16 B 8 C 14 D 7

PIP1 PIP Performance Improvement Program in Surgical Pathology, Additional Pathologist

265 A 16 B 8 C 14 D 7

PIPW PIPW Online Performance Improvement Program, Surgical Pathology

264 A 16 B 8 C 14 D 7

PIPW1 PIPW Online Performance Improvement Program, Surgical Pathology, Additional Pathologist

264 A 16 B 8 C 14 D 7

PLA PLA Lipoprotein-Associated Phospholipase A2 75 A 30 B 28

PLTM PLTM Platelet Mapping 169 A 9 B 12

PM1 PM1 CD117, IHC Tissue Microarray 279 A 30

PM2 PM2 ER/PgR, IHC Tissue Microarray 281 A 26 B 2

PM3 PM3 CD20, IHC Tissue Microarray 279 A 23 B 14

PM5 PM5 IHC Tissue Microarray Series 280 A 20

PM6 PM6 Anaplastic Lymphoma Kinase IHC TMA 280 A 23 B 8

PNA1 PNA PNA FISH for Staphylococcus 179 A 20 B 19

PNA2 PNA PNA FISH for Yeast 179 A 20 B 19

PNH* PNH Flow Cytometry—PNH Immunophenotyping 217 A 28 B 27

POC1 POC1 POC hCG Competency 52 May be purchased any time during the year

POC2 POC2 POC Glucose Competency 52 May be purchased any time during the year

POC3 POC3 POC Urine Dipstick Competency 52 May be purchased any time during the year

POC4 POC4 POC Strep Screen Competency 52 May be purchased any time during the year

POC6 POC6 POC PT/INR, CoaguChek XS+ Competency 52 May be purchased any time during the year

POC7 POC7 POC Waived Glucose & Hemoglobin Competency

52 May be purchased any time during the year

POC8 POC8 POC Influenza A/B Antigen Detection Competency


POC9 POC9 POC Fecal Occult Blood Competency 52 May be purchased any time during the year

POC10 POC10 POC Blood Gases Competency 53 May be purchased any time during the year

POC11 POC11 POC Blood Gases, i-STAT Competency 53 May be purchased any time during the year

POC12 POC12 POC Plasma Cardiac Markers Competency 53 May be purchased any time during the year


Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


POC14 POC14 POC Medtronic ACT/ACT, i-STAT Competency


POC15 POC15 POC Hemochron Jr IL GEM ACT-LR Competency


POC16 POC16 POC Hemochron Jr Signature IL GEM Competency


PS PS Platelet Serology 225 A 16 B 19

PTHQ PTHQ Quality Cross Check—Parathyroid Hormone

43 A 18 B 9

PV SEM Semen Analysis 156 A 20 B 26

PV1 SEM Postvasectomy Sperm Count—Automated 156 A 20 B 26

QF QF M. tuberculosis-Stimulated Infection Detection

213 A 18 B 19

QP201 QPR Technical Competency Assessment of Peripheral Blood Smears

25 A 9**

QP202 QPR Red Blood Cell Utilization: Single and Double Unit Transfusions

26 B 16

QP203 QPR Inpatient Test Utilization and Volume Benchmarking

27 C 8

QP204 QPR Turnaround Time for Image-Guided Breast Needle Biopsy Specimens

28 D 31

PRO QPR Four Q-PROBES Studies 22 B 16 C 8 D 31 A 9**

QT1 QTR Patient Identification Accuracy 31 B 2 C 1 D 31 A 9**

QT2 QTR Blood Culture Contamination 31 B 2 C 1 D 31 A 9**

QT3 QTR Laboratory Specimen Acceptability 32 B 2 C 1 D 31 A 9**

QT4 QTR In-Date Blood Product Wastage 32 B 2 C 1 D 31 A 9**

QT5 QTR Gynecologic Cytology Outcomes 37 B 2 C 1 D 31 A 9**

QT7 QTR Satisfaction with Outpatient Specimen Collection

33 B 2 C 1 D 31 A 9**

QT8 QTR Stat Test Turnaround Time Outliers 33 B 2 C 1 D 31 A 9**

QT10 QTR Critical Values Reporting 34 B 2 C 1 D 31 A 9**

QT15 QTR Troponin Turnaround Times 35 B 2 C 1 D 31 A 9**

QT16 QTR Corrected Results 36 B 2 C 1 D 31 A 9**

QT17 QTR Outpatient Order Entry Errors 36 B 2 C 1 D 31 A 9**

QTC QTR Clinical Pathology Monitors 22 B 2 C 1 D 31 A 9**

QTP QTR CP/AP Q-TRACKS Monitors 22 B 2 C 1 D 31 A 9**

R R Trace Metals 78 A 31 B 27

RAG RAG Red Blood Cell Antigen Genotyping 223 A 23 B 19

RAP Y Renin and Aldosterone 89 A 27 B 21

RBCAT RBCAT Red Blood Cell Antigen Typing 223 A 23 B 2

RDS RDS Rheumatic Disease Special Serologies 213 A 6 B 17

**This ship date is in December 2019

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 19

Prog Code

PFGCode


RETT RETT CAP/ACMG Rett Syndrome (MECP2) 251 A 2 B 14

RF S Rheumatoid Factor 208 A 23 B 17 C 16

RFAV1 RFAV Rare Flow Antigen Validation, CD1a 218 A 21 B 20

RFAV2 RFAV2 Rare Flow Antigen Validation, CD103 218 A 21 B 20

RFX S Rheumatoid Factor, Double Volume 208 A 23 B 17 C 16

RHCVW RHCVW Anti-HCV, Rapid Methods, Waived 231 A 27 B 2

RMAL RMAL Rapid Malaria 193 A 26 B 16

RMC RMC Routine Microbiology Combination 176 A 30 B 10 C 7

RNA RNA Fusion RNA 260 A 24 B 18

ROM1 ROM1 Placental Alpha Microglobulin 1 (PAMG-1) 152 A 11 B 14

RT RT Reticulocyte 141 A 27 B 14

RT2 RT2 Reticulocyte 141 A 27 B 14


RT3Q RT3Q Quality Cross Check—Reticulocyte 45 A 15 B 14


RT4Q RT4Q Quality Cross Check—Reticulocyte 45 A 15 B 14

RTQ RTQ Quality Cross Check—Reticulocyte 45 A 15 B 14

RUB S Rubella 208 A 23 B 17 C 16

RUBX S Rubella, Double Volume 208 A 23 B 17 C 16

RUR RUR Rapid Urease 183 A 27 B 10

RVBN ACM Rivaroxaban Anticoagulant Monitoring 163 A 14 B 26

RWBC RWBC Rapid Total Whole Blood Cell Count 140 A 14 B 17 C 7

S2 S2 Immunology—Special 209 A 6 B 10 C 14

S4 S2 Immunology—Special, Limited 209 A 6 B 10 C 14

S5 S2 Immunology—Special, H. pylori IgG Antibody

209 A 6 B 10

SALC SALC Salivary Cortisol 77 A 14 B 1

SARC SARC Sarcoma Translocation 259 A 12 B 24

SBAS BAS S. pneumoniae Antigen Detection 178 A 2 B 9

SC SEM Sperm Count 156 A 20 B 26

SC1 SEM Automated Sperm Count 156 A 20 B 26

SCDD SCDD Synthetic Cannabinoid/Designer Drugs 105 A 30 B 21

SCM1 SCM Urine Hemosiderin, Prussian Blue 152 A 16 B 9

SCM2 SCM Urine Eosinophils, Wright Stain 152 A 16 B 9

SCO SCO Serum Carryover 134 A 11

SCP SCP Stem Cell Processing 227 A 7 B 13

SCS SCS Sickle Cell Screening 142 A 2 B 10

SDS SDS Serum Drug Screening 101 A 23 B 2

SE SE Diagnostic Allergy 213 A 30 B 10 C 23

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


SEC SEC CAP/ACMG DNA Sequencing Interpretation 250 A 20 B 7

SEC1 SEC1 CAP/ACMG DNA Sequencing 250 A 27 B 26

SFLC SFLC Serum Free Light Chains 214 A 13 B 12

SM SEM Sperm Morphology 156 A 20 B 26

SM1CD SPCD Sperm Morphology, Online 156 A 20 B 26

SM2CD SPCD Sperm Viability, Online 156 A 20 B 26

SMCD SPCD Sperm Count and Motility, Online 156 A 20 B 26

SO SO Blood Oximetry 94 A 24 B 13 C 26

SOQ SOQ Quality Cross Check—Blood Oximetry 44 A 20 B 31

SP SP Stool Pathogens 184 A 18 B 2

SP1 SP Norovirus 184 A 18 B 2

SPE ELP Protein Electrophoresis 76 A 27 B 10

SPN SP Stool Pathogen, without Shiga Toxin 184 A 18 B 2

ST ST Shiga Toxin 184 A 18 B 3

STFR STFR Soluble Transferrin Receptor 80 A 20 B 24

SV SEM Sperm Viability 156 A 20 B 26

SW1 SW Sweat Analysis 79 A 21 B 13



T T Toxicology 96 A 2 B 20 C 12

TBLA TBLA Total Bile Acids 78 A 21 B 17

THCB THCB Blood Cannabinoids 106 A 14 B 31

TICP TICP Touch Imprint/Crush Preparation 288 A 22 B 14

TICP1 TICP Touch Imprint/Crush Prep, Additional Participant

288 A 22 B 14

TM TM Tumor Markers 89 A 6 B 20

TMCA TMCA Transfusion Medicine Comprehensive—Competency Assessment

225 A 10 B 8 C 8

TMCAD TMCAD Direct Antiglobulin Test—Competency Assessment

225 A 24 B 12

TMCAE TMCAE Eluate Competency Assessment 226 A 16 B 29

TMCAF TMCAF Fetal Red Cell Quantitation—Competency Assessment

226 A 27 B 2

TMO TMO Ticks, Mites, and Other Arthropods 194 A 10 B 27

TMU TMU Trace Metals, Urine 103 A 10 B 10

TMWB TMWB Trace Metals, Whole Blood 103 A 23 B 28

TMX TM Tumor Markers, Double Volume 89 A 6 B 20

TNT CAR Troponin T, 2 Challenge 62 A 17 B 19 C 6

TNT5 CAR Troponin T, 5 Challenge 62 A 17 B 19 C 6

Surveys P

rogram S

hipping


SM



800-323-4040 | 847-832-7000 Option 1 | cap.org 21

Prog Code

PFGCode


TPM TPM CAP/ACMG Thrombophilia Mutations 252 A 16 B 21

TRC TRC Transfusion-Related Cell Count 224 A 6 B 11 C 24

TTD TTD Tick Transmitted Diseases 205 A 10 B 14

TVAG TVAG T. vaginalis, Molecular 186 A 18 B 16

U U Urine Chemistry—General 68 A 2 B 13

UAA UAA Automated Urine Microscopy 149 A 16 B 27

UAA1 UAA1 Automated Urine Microscopy 149 A 16 B 27

UBJP ELP Urine Bence Jones Protein 76 A 27 B 10

UDC UDC CAP/AACC Forensic Urine Drug Test, Confirmatory

99 A 6 B 27 C 27 D 2

UDS UDS CAP/AACC Urine Drug Testing, Screening 98 A 9 B 15 C 5

UDS6 UDS6 CAP/AACC Urine Drug Testing, Screening, Ltd

98 A 9 B 5

UDSM UDSM Urine Drug Testing, Screen, Validated Material

109 A 9 B 15 C 5

UHCG UHCG Urine hCG 152 A 24 B 17 C 14

UMC UMC Urine Albumin and Creatinine, Semiquant 153 A 18 B 21

UPBG UPBG Porphobilinogen, Urine 70 A 27 B 2

URC CRS Urine Crystals 149 A 29 B 30

UT UT Urine Toxicology 96 A 2 B 20 C 12

UTCO UTCO Urine Toxicology Carryover 134 A 11

UVM UVM Urine Chemistry—General, Validated Material

70 A 2 B 13

V V Viscosity 214 A 6 B 5

VBDM VBDM Vector-Borne Disease—Molecular 200 A 26 B 7

VBF VBF Virtual Body Fluid 148 A 30 B 31

VBP VBP Virtual Biopsy Program 266 A 24 B 26 C 24 D 2

VBP1 VBP Virtual Biopsy Program, Additional Pathologist

266 A 24 B 26 C 24 D 2

VES VES Viscoelastic Studies 166 A 13 B 24

VF VF Vitreous Fluid, Postmortem 101 A 10 B 10

VGS1 VGS1 Virtual Gram Stain Basic Competency 177 A 20 B 19

VGS2 VGS2 Virtual Gram Stain Advanced Competency 177 A 20 B 19

VIP VIP Variant Interpretation Only 252 A 27

VIP1 VIP Variant Interpretation Only, Additional Participant

252 A 27

VITD VITD 25-OH Vitamin D, Total 84 A 27 B 23

VLS VLS BK, CMV, and EBV Viral Load 199 A 27 B 22

VLS2 VLS Viral Load 199 A 27 B 22 C 30

Sur

veys

Pro

gram

Shi

ppin

g


SM




Prog Code

PFGCode


VM1 VM Viral Markers—Series 1 230 A 21 B 11 C 24


VM3 VM Viral Markers—Series 3 230 A 21 B 11

VM4 VM Viral Markers—Series 4 230 A 21 B 11



VM6X VM Viral Markers—Series 6, Additional Material

231 A 21 B 11 C 24

VPBS VPBS Virtual Peripheral Blood Smear 143 A 6 B 27

VR1 VR1 Virology Culture 196 A 27 B 18 C 21

VR2 VR2 Virology Antigen Detection (DFA) 196 A 16 B 13 C 2

VR3 VR3 Infectious Disease Serology 205 A 16 B 2

VR3M VR3 Infectious Disease Serology, Mumps 205 A 16 B 2

VR4 VR4 Virology Antigen Detection (Non-DFA) 196 A 3 B 4 C 9

VRE VRE Vancomycin-resistant Enterococcus 187 A 20 B 24

VS VS Vaginitis Screen Antigen Detection 185 A 30 B 27 C 26

VS1 VS Vaginitis Screen, T. vaginalis 185 A 30 B 27

VS2 VS2 Vaginitis Screen, Virtual Gram Stain 186 A 10 B 6

WBCR WBCR Whole Blood Creatinine 66 A 23 B 27 C 23

WBGQ WBGQ Quality Cross Check—Whole Blood Glucose 41 A 30 B 8

WID WID Worm Identification 194 A 30 B 2

WP3 WP3 Whole Blood PT/INR, i-STAT 168 A 10 B 4 C 21

WP4 WP4 Whole Blood Citrated PT Hemochron/IL GEM

168 A 10 B 4 C 21

WP6 WP6 Whole Blood Non-Citrated PT Hemochron/IL GEM

168 A 10 B 4 C 21

WP9 WP9 Whole Blood Coagulation—CoaguChek, XS Plus

168 A 27 B 18 C 31

WP10 WP10 Whole Blood Coagulation—CoaguChek XS System

168 A 18 B 31

Y Y Ligand—Special 84 A 27 B 21

YVM YVM Ligand—Special, Validated Material 90 A 27 B 21

YY Y Ligand—Special, Additional Volume 84 A 27 B 21

Z C TDM—General, Comprehensive 56–58 A 9 B 1 C 28

ZAP70 ZAP70 ZAP-70/CD49d Analysis by Flow Cytometry 218 A 2 B 10

ZE ZE Therapeutic Drug Monitoring—Extended 60 A 10 B 10

ZT ZT Therapeutic Drug Monitoring—Special 60 A 9 B 23

Surveys P

rogram S

hipping2020 Surveys Program Shipping

800-323-4040 | 847-832-7000 Option 1 | cap.org 23

2020 PAP Shipping

PAP Proficiency Testing With Education

DescriptionProgram Code (Institution)

Program Code (Individual) Page Calendar of Shipment Dates

PAP PT

PAPCPT (Conventional) APAPCPT 285

Laboratory will choose one of 20 dates for testing event

Feb 3

Mar 2

April 6

May 4

June 1

July 6

Aug 3

Sept 8

Oct 5

Nov 2

Feb 18

Mar 16

April 20

May 18

June 15

July 20

Aug 17

Sept 21

Oct 19

Nov 16

PAPKPT (SurePath) APAPKPT 285

PAPJPT (Combination) APAPJPT 285

PAPLPT (Liquid Based) APAPLPT 285

PAPMPT (ThinPrep) APAPMPT 285

Education No additional charge

Laboratory must choose from Series 1 or 2

Series 1, A mailing: February 10-March 2 Series 1, B mailing: August 10-August 31

Series 2, A mailing: May 11-June 1 Series 2, B mailing: November 2-November 23

Enrollment for laboratories with CLIA license with enrollees testing at affiliated sites

PPTENR 285 No shipments associated with this program

For additional programs for PAP PT, such as extra tests, retests, CAP provided proctors, and locum tenens, please call a Customer Contact Representative at 800-323-4040 or 847-832-7000 option 1.

PAP Education

DescriptionProgram Code (Institution)

Program Code (Individual) Page Calendar of Shipment Dates

PAP Education (Series 1 or 2)

PAPCE1 or 2 (Conventional) APAPCE1 or 2 286 Laboratory must choose from Series 1 or 2

PAPKE1 or 2 (SurePath) APAPKE1 or 2 586

Series 1, A mailing: February 10-March 2 Series 1, B mailing: August 10-August 31PAPJE1 or 2

(Combination) APAPJE1 or 2 286

PAPLE1 or 2 (Liquid Based) APAPLE1 or 2 286

Series 2, A mailing: May 11-June 1 Series 2, B mailing: November 2-November 23PAPME1 or 2

(ThinPrep) APAPME1 or 2 286

For international laboratories and other laboratories not subject to US regulations, that perform gynecologic cytopathology, participation in the CAP Cytopathology Glass Slide Education Program will fulfill the checklist requirement for participation in an interlaboratory peer-comparison educational program in gynecologic cytopathology.

Sur

veys

Pro

gram

Shi

ppin

g

Quality Management Tools Overview



2020 Q-PROBESModules/Packages Program Codes

Individual QP Studies QP201, QP202, QP203, QP204

All Four QP Studies PRO

2020 Q-TRACKSModules/Packages Program Codes

Individual Clinical Pathology (CP) MonitorsQT1, QT2, QT3, QT4, QT7, QT8,

QT10, QT15, QT16, QT17

Individual Anatomic Pathology (AP) Monitor QT5

Combined CP/AP Module – Includes all 11 QT Monitors QTP

Clinical Pathology Module – Includes all 10 CP Monitors QTC

Refer to the Quality Management Tools section of the Surveys catalog for program information.

Competency Assessment and Safety & Compliance Program

Your laboratory’s license for Competency Assessment Program is based on the number of individuals who will be using Competency Assessment Program—that is, the number of people for whom you will be assessing competency, not the number of employees in your laboratory. The Safety & Compliance course package is an addition to your Competency Assessment Program order. The same employees enrolled in Competency Assessment Program will have access to Safety & Compliance courses if the additional fee is paid. Refer to pages 15–17 of the Surveys catalog for program information.

Number of Users

Competency Assessment Program Safety & Compliance Courses**

Program Code Program Code

Up to 50 CA0050 XCA0050

51 to 250* CA0250 XCA0250

*More than 250 users: Call 800-323-4040 or 847-832-7000 option 1.

**Safety & Compliance course package must be purchased in conjunction with Competency Assessment Program subscription. Not available for purchase separately.

surveys program shipping - college of american pathologists€¦ · surveys program shipping. look...

Documents